Navigation Links
Obese Men Face Twin Threat From Prostate Cancer
Date:8/8/2008

Delayed diagnosis, less successful surgery, pair of studies finds

FRIDAY, Aug. 8 (HealthDay News) -- The standard screening test for prostate cancer may not be accurate for obese men, leaving them more vulnerable to the disease, and surgery is less likely to be effective for them, a new pair of studies found.

"Obese men are more likely to be diagnosed with an aggressive form of the disease," said Dr. Stephen Freedland, an associate professor of urology and pathology at the Duke University Prostate Center, and an author of one of the studies.

The reason: The blood test that looks for elevated levels of the protein prostate-specific antigen (PSA), indicating a heightened cancer risk, doesn't seem as reliable for obese men, Freedland said.

"Our assumption is that these men have more blood volume, so PSA gets diluted, he said. "By the time obese men get to elevated levels, the cancer is more advanced."

The study, published online Friday in the journal BJU International included nearly 3,400 men who had PSA tests. The researchers found that the risk of an aggressive cancer was doubled in obese men diagnosed because of high PSA levels. No such association was found for obese men diagnosed by a digital rectal examination, in which the physician feels for an abnormally large prostate gland.

Prostate cancer is suspected when the PSA reading is 4 or higher. The current recommendation is for men aged 50 and older to be offered an annual PSA test, with explanations of its possible risks and benefits. A federal preventive medicine committee this week said that PSA screening should not be done for men aged 75 and older because the risks outweigh the benefits.

"I'm not sure that we should check obese men more often," Freedland said. "But we should have a higher [PSA] index of suspicion of what is not normal -- 3.4 rather than 4; for really obese men, 3.2."

The Duke study measured ob
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. PSA screening may be biased against obese men, leading to more aggressive cancers
2. Studies refute common stereotypes about obese workers
3. Research highlights problems of predicting birthweights in obese mothers
4. Minimally-invasive weight loss surgery improves health and morbidly obese teens
5. Obese women in Canada are less likely to be screened for cervical cancer
6. Standard Glucose Test May Be Wrong One for Obese Children
7. 1 out of 4 obese school-aged children suffers metabolic syndrome
8. Brisk Walking Lowers Blood Pressure, Increases Fitness in Obese
9. Obese Patients at Greater Infection Risk After Hip Replacement
10. AUA 2008: Gastric bypass surgery restores sexual function in morbidly obese men
11. Obese patients face increased risks for infection and dislocation following revision hip surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Late recurrence is a risk for some pediatric cance...central nervous system, according to a new study p...National Cancer Institute . , This study was und...recurrence (after 5 years and up to 20 years) for ...sker, M.D., of the Aflac Cancer Center and Blood D...
(Date:12/4/2009)...Case Western Reserve University researchers, from ...discovered two new metabolic pathways by which pro...e, known as 4-hydroxyacids, are metabolized. The p...lomics and mass isotopomer analysis. The findings ...rug of abuse gamma-hydroxybutyrate, also known as ...
(Date:12/4/2009)... Dental tourism is a phenom...for an alternative to the high price of dental wor... search for lower priced dental care, people have ...ce as a dental tourist destination. , ...ng in business for more than 6 years, Mexican Dent...
(Date:12/4/2009)...ve a response to pressure from federal regulators ... , FRIDAY, Dec. 4 (HealthDay News) -- The ma...riday presented federal regulators with plans to c...rmaceutical companies have been under pressure fro...ind a way to stop the hundreds of fatal overdoses ...
(Date:12/4/2009)...search and surveillance urged for at-risk patient ...s) -- Some childhood cancers, particularly Ewing s...he risk of late recurrence, U.S. researchers have ...2,795 five-year survivors of the most common pedia...ncer Survivor Study. , The researchers found th...
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...e of Fayette,County,s largest employers will expan...of an $8.4 million, 20-year investment by the comm...,000 grant each year through the,Fayette County Re...uction of a new,inpatient tower that will hold 56 ...
...ants for Families and Honors for Corporate Suppor...ies Affected, GURNEE, Ill., Nov. 5 This year you...oney for pediatric cancer research and,families of...uper hero costumes at this year,s Super Jake Found...
...Heart,Association and its Pharmaceutical Roundtabl...he Outcomes Research Centers initiative. The proje...troke research focusing on,the end results, or out...eart Association national board member David Spina...
...agni, President,and CEO of America,s Health Insura...ment congratulating President-elect Barack Obama:,...r his historic victory,last night. Now is the time... care challenges facing the nation. We,support cov...
...he American,Nurses Association (ANA) congratulates...tory, and looks forward to working with the new ad...change for nurses and the patients we,serve., Pre...wn a commitment to advancing the nursing professio...
...ward to health system reform in 2009, WASHINGTON,...lsen, M.D., AMA President:, "The American Medical...Obama on his successful bid for the presidency of ... President-elect Obama,s focus on expanding health...
Other Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 3Health News:Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke 2Health News:AMA Congratulates President-Elect Obama 2
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-Fir...PI ), a leading global specialty pharmaceutical co... Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market it... a patent owned by Takeda Pharmaceutical Company L...
(Date:12/4/2009)... , BETHESDA, Md., Dec. 4 Drs....s for prostate-specific antigen (PSA) recurrence f...s of biochemical recurrence rate in a Phase III pi...or injection) or monthly leuprolide in prostate ca... Prostate cancer patients who received FIRMAGON 24...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Firs...ed that the US Food and Drug Administration (FDA) ...ine fumarate) Extended Release Tablets as adjuncti... with Major Depressive Disorder (MDD). SEROQUEL XR...he FDA to treat both major depressive disorder as ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Novel K anonymity algorithm safeguards access to data 61811 1Flax and yellow flowers can produce bioethanol 10835 1Flax and yellow flowers can produce bioethanol 10835 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 1Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 3
...06, Demonstrated No Reproductive Toxicity in ... Selected as Clinical Candidate, Demonstrated a 40...ce Daily Oral Dosing -, SAN DIEGO, May 22 Ardea ... preclinical data on its lead non-nucleoside,rever...806, demonstrating,no reproductive toxicity. In ad...
...ull Data Set from the TRIUMPH-1 Trial of Inhaled ...SPRING, Md., May 21 United,Therapeutics Corporati...y,Lung Rx, Inc. today announced that data from sev...nary arterial hypertension (PAH) with treprostinil...TS) meeting in Toronto,Ontario. The ATS presentati...
Other Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
AFP EIA Kit
Medicine Products: